Hypertriglyceridemia is a frequent complication among patients on CAPD, especially in those with abnormal triglycerides at the beginning of treatment. Diabetics on CAPD do not develop hypertriglyceridemia. HDL C is low at the initiation of CAPD and does not decrease further during CAPD. In those patients who have initial normal triglyceride levels, HDL C increased with time on CAPD at least for four to six months.
Get full access to this article
View all access options for this article.
References
1.
LowrieE.C., LazarusI.M., MocelinAI.Survival of patients undergoing chronic hemodialysis and renal transplantation.N Engl I Med1973; 288: 863–867.
2.
HaireH.M., SherrardIll. Scardapan D. Smoking. hypertension and mortality in a maintenance dialysis population.Cardiovasc Med1978; 3: 1163–1168.
3.
BagdadeI.D., PorteD Ir, BiermanE.L.Hypertriglyceridemia: A metabolic consequence of chronic renal failure.N Engl I Med1968; 279: 181–185.
4.
Brunzel1I.D., AlbersI.I., HaasL.D.Prevalence of serum lipid abnormalities in chronic hemodialysis.Metabolism1977; 26: 903–910.
5.
IbelsL.D., ReardonM.F., NestelP.I.Plasma postheparin lipolytic activity and triglyceride clearance in uremia and hemodialysis patients and renal allograft recipients.I Lab Clin Med1976; 27: 648.
6.
NovariniA., ZulianiU., BandiniL.Observations on lipid metabolism in chronic renal failure during conservative and hemodialysis therapy.Eur I Clin Invest1976; 6: 473.
7.
IbelsL.S., SimonsL.A., KingI.O.Studies on the nature and causes of hyperlipemia, maintenance dialysis and renal transplantation.Q I Med1975; 44: 601.
8.
LowrieE.C., LazarusI.M., MocelinA.I.Survival of patients undergoing chronic hemodialysis and renal transplant.N Engl I Med1973; 288: 863.
9.
CasarettoA., MarchioroT., BagdadeI.Hyperlipidemia following renal transplantation.Trans Am Soc Artif Intern Organs1973; 19: 154.
10.
LindnerA., CharraB., SherrardIll, ScribnerB.H.Accelerated atherosclerosis in prolonged maintenance hemodialysis.N Engl I Med1974; 290: 697–701.
11.
FredericksonD.S., LevyRl, LeesR.S.Fat transport in lipoproteins -an integrated approach to mechanisms and disorders.N Engl I Med1967; 276: 34–44. 94–103. 215–225,273–281.
12.
CattranD.C., FentonS.S.A., WilsonD.R., SteinerG.Defective triglyceride removal in lipemia associated with peritoneal dialysis and hemodialysis. Ann.Intern Med1976; 85: 29–33.
13.
OreopoulosD.G., KaranicolasS.Izatt S. deVeber GA. Dialysis and triglycerides.Ann Intern Med1976; 85: 679–680.
OreopoulosD.G., RobsonM., IzattS.A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD).Trans Am Soc Artif Intern Organs1978; 24: 484–489.
16.
OreopoulosD.G., KhannaR., McCreadyW.Continuous ambulatory peritoneal dialysis in Canada.Dial and Transplant1980; 9: 224–226.
17.
SomerI.B., AbbottL., AitkenI.M.Combined hyperlipidemia and hyper-triglyceridemia in renal allograft recipients. Comparison with non-renal combined hyperlipidemic or hypertriglyceridemic patients and normal subjects.Clin Chim Acta1979; 97: 123–134.
18.
HuttunenI.K., PasternackA., VanttinenT.Lipoprotein metabolism in patients with chronic uremia.Acta Med Scand1978; 204: 211–218.
19.
GoldbergA., Sherrardill, BrunzellI.D.Adipose tissue lipoprotein lipase in chronic hemodialysis: Role in plasma triglyceride metabolism.I Clin Endocrinol1978; 47: 1173–1182.
